Multivariate Analysis of Serum High Sensitivity C-Reactive Protein in Patients With Acute Phase Stroke (MAASP)

June 21, 2014 updated by: Jorge Yanez, Hospital Central Sur de Alta Especialidad
Stroke is one of main causes of death and impairment worldwide. Objective of this study is to analyze serum High Sensitivity C-Reactive Protein in acute phase stroke in patients attended at Petróleos Mexicanos Hospital Central Sur de Alta Especialidad and to correlate with stroke extension and clinical features.

Study Overview

Status

Unknown

Conditions

Study Type

Observational

Enrollment (Anticipated)

28

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Mexico
    • Tlalpan
      • Mexico city, Tlalpan, Mexico, 14140
        • Hospital Central Sur Alta Especialidad

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients affiliated to Petróleos Mexicanos medical system of any gender between 18 and 80 years old suspected of acute phase stroke who arrive to emergency room at our hospital

Description

Inclusion Criteria:

  • Patients suspected of acute phase stroke who arrive to emergency room at our hospital
  • Patients affiliated to Petróleos Mexicanos medical system
  • Patients of any gender
  • Patients between 18 and 80 years old

Exclusion Criteria:

  • Stroke provoked by angiographic procedure
  • Pregnancy
  • Patient under chemotherapy or radiotherapy
  • Recently surgery or trauma among last 30 days
  • Heparin usage
  • Stroke and/ or thrombolysis history
  • Active infection
  • Liver disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
stroke
Patients admitted to hospital who are diagnosed with stroke will be treated as usually a our center by observation, venous or arterial thrombolysis depending on extension, condition, thrombolysis feasibility.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measure of serum High sensitivity C-Reactive Protein level
Time Frame: within the first 8 hours since admission to hospital
Serum levels of serum High sensitivity C-Reactive Protein will be measured in patients with suspicion of stroke at the emergency room within the first 8 hours of arrival at our hospital
within the first 8 hours since admission to hospital

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
National Institutes of Health Stroke Scale
Time Frame: within the first 4 hours since admission to emergency room
clinical impact of stroke will be determined by neurology and neurosurgery department at admission to emergency room of our hospital
within the first 4 hours since admission to emergency room

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stroke extension
Time Frame: within the first 4 hours since admission to emergency room
brain image will be taken as soon as possible when patient suspected with stroke arrives to emergency room and after clinical evaluation
within the first 4 hours since admission to emergency room
Origin of stroke
Time Frame: origin will be diagnosed during the hospital stay expecting no more than 1 week
origin of stroke will be investigated within hospital stay
origin will be diagnosed during the hospital stay expecting no more than 1 week
Hospital stay
Time Frame: hospital stay is expected for no more than 1 week unless intensive care unit is needed
from arrival of patient to emergency room until discharge
hospital stay is expected for no more than 1 week unless intensive care unit is needed

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hospital Central Sur de Alta Especialidad

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2013

Primary Completion (Anticipated)

January 1, 2015

Study Registration Dates

First Submitted

June 4, 2014

First Submitted That Met QC Criteria

June 21, 2014

First Posted (Estimate)

June 24, 2014

Study Record Updates

Last Update Posted (Estimate)

June 24, 2014

Last Update Submitted That Met QC Criteria

June 21, 2014

Last Verified

June 1, 2014

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CRP-S1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe